Overslaan en naar de inhoud gaan

 Wetenschapelijke artikelen

Evidence-based approaches for the management of side-effects of adjuvant endocrine therapy in patients with breast cancer.

Auteurs : Franzoi MA, Agostinetto E, Perachino M, Del Mastro L, de Azambuja E, Vaz-Luis I, Partridge AH, Lambertini M
Jaar : 2021
Journal : Lancet Oncol
Volume : 22
Pagina's : e303-e313

Impact of COVID-19 on social media as perceived by the oncology community: results from a survey in collaboration with the European Society for Medical Oncology (ESMO) and the OncoAlert Network.

Auteurs : Morgan G, Tagliamento M, Lambertini M, Devnani B, Westphalen B, Dienstmann R, Bozovic-Spasojevic I, Calles A, Criscitiello C, Curioni A, Garcia AM, Lamarca A, Pilotto S, Scheffler M, Strijbos M, Wong R, de Azambuja E, Peters S
Jaar : 2021
Journal : ESMO Open
Volume : 6
Pagina's : 100104

OncoAlert Round Table Discussions: The Global COVID-19 Experience.

Auteurs : Morgan G, de Azambuja E, Punie K, Ades F, Heinrich K, Personeni N, Rahme R, Ferrara R, Pels K, Garassino M, von Bergwelt-Baildon M, Lopes G, Barlesi F, Choueiri TK, Burris H, Peters S
Jaar : 2021
Journal : JCO Glob Oncol
Volume : 7
Pagina's : 455-463

Emerging Therapeutics for Patients with Triple-Negative Breast Cancer.

Auteurs : Agostinetto E, Eiger D, Punie K, de Azambuja E
Jaar : 2021
Journal : Curr Oncol Rep
Volume : 23
Pagina's : 57

Updated results from the international phase III ALTTO trial (BIG 2-06/Alliance N063D).

Auteurs : Moreno-Aspitia A, Holmes EM, Jackisch C, de Azambuja E, Boyle F, Hillman DW, Korde L, Fumagalli D, Izquierdo MA, McCullough AE, Wolff AC, Pritchard KI, Untch M, Guillaume S, Ewer MS, Shao Z, Sim SH, Aziz Z, Demetriou G, Mehta AO, Andersson M, Toi M, Lang I, Xu B, Smith IE, Barrios CH, Baselga J, Gelber Rd, Piccart-Gebhart M
Jaar : 2021
Journal : Eur J Cancer
Volume : 148
Pagina's : 287-296

The Exciting New Field of HER2-Low Breast Cancer Treatment.

Auteurs : Eiger D, Agostinetto E, Saude Conde R, de Azambuja E
Jaar : 2021
Journal : Cancers (Basel)
Volume : 13

Clinical outcomes of platinum-based chemotherapy in patients with advanced breast cancer: An 11-year single institutional experience.

Auteurs : Franzoi MA, Saude Conde R, Ferreira SC, Eiger D, Awada A, de Azambuja E
Jaar : 2021
Journal : Breast
Volume : 57
Pagina's : 86-94

CDK4/6 inhibitors as adjuvant treatment for hormone receptor-positive, HER2-negative early breast cancer: a systematic review and meta-analysis.

Auteurs : Agostinetto E, Vian L, Caparica R, Bruzzone M, Ceppi M, Lambertini M, Pondé N, de Azambuja E
Jaar : 2021
Journal : ESMO Open
Volume : 6
Pagina's : 100091

Cardiotoxicity of immune checkpoint inhibitors: A systematic review and meta-analysis of randomised clinical trials.

Auteurs : Agostinetto E, Eiger D, Lambertini M, Ceppi M, Bruzzone M, Pondé N, Plummer C, Awada A, Santoro A, Piccart-Gebhart M, de Azambuja E
Jaar : 2021
Journal : Eur J Cancer
Volume : 148
Pagina's : 76-91

CDK4/6 and PI3K inhibitors: A new promise for patients with HER2-positive breast cancer.

Auteurs : Agostinetto E, Debien V, Marta GN, Lambertini M, Piccart-Gebhart M, de Azambuja E
Jaar : 2021
Journal : Eur J Clin Invest
Pagina's : e13535

Beta-blockers in early-stage breast cancer: a systematic review and meta-analysis.

Auteurs : Caparica R, Bruzzone M, Agostinetto E, de Angelis C, Fêde Â, Ceppi M, de Azambuja E
Jaar : 2021
Journal : ESMO Open
Volume : 6
Pagina's : 100066

Pregnancy After Breast Cancer: A Systematic Review and Meta-Analysis.

Auteurs : Lambertini M, Blondeaux E, Bruzzone M, Perachino M, Anderson RA, de Azambuja E, Poorvu PD, Kim HJ, Villarreal-Garza C, Pistilli B, Vaz-Luis I, Saura C, Ruddy KJ, Franzoi MA, Sertoli C, Ceppi M, Azim HA Jr, Amant F, Demeestere I, Del Mastro L, Partridge AH, Pagani O, Peccatori FA
Jaar : 2021
Journal : J Clin Oncol
Volume : 39
Pagina's : 3293-3305

Genomic and Transcriptomic Analyses of Breast Cancer Primaries and Matched Metastases in AURORA, the Breast International Group (BIG) Molecular Screening Initiative.

Auteurs : Aftimos P, Oliveira M, Irrthum A, Fumagalli D, Sotiriou C, Gal-Yam EN, Robson ME, Ndozeng J, Di Leo A, Ciruelos EM, de Azambuja E, Viale G, Scheepers ED, Curigliano G, Bliss JM, Reis-Filho JS, Colleoni M, Balic M, Cardoso F, Albanell J, Duhem C, Marreaud S, Romagnoli D, Rojas B, Gombos A, Wildiers H, Guerrero-Zotano A, Hall P, Bonetti A, Larsson KF, Degiorgis M, Khodaverdi S, Greil R, Sverrisdóttir Á, Paoli M, Seyll E, Loibl S, Linderholm B, Zoppoli G, Davidson NE, Johannsson OT, Bedard PL, Loi S, Knox S, Cameron DA, Harbeck N, Montoya ML, Brandão M, Vingiani A, Caballero C, Hilbers FS, Yates LR, Benelli M, Venet D, Piccart MJ
Jaar : 2021
Journal : Cancer Discov
Volume : 11
Pagina's : 2796-2811

HER2-Low Breast Cancer: Molecular Characteristics and Prognosis.

Auteurs : Agostinetto E, Rediti M, Piccart-Gebhart M, Fimereli D, Debien V, Aftimos P, Sotiriou C, de Azambuja E
Jaar : 2021
Journal : Cancers (Basel)
Volume : 13

Emerging issues related to COVID-19 vaccination in patients with cancer.

Auteurs : Saini KS, Martins-Branco D, Tagliamento M, Vidal L, Singh N, Punie K, Saini ML, Chico I, Curigliano G, de Azambuja E, Lambertini M
Jaar : 2021
Journal : Oncol Ther
Pagina's : 1-11

Adjuvant Olaparib for Patients with <i>BRCA1</i>- or <i>BRCA2</i>-Mutated Breast Cancer.

Auteurs : Tutt ANJ, Garber JE, Kaufman B, Viale G, Fumagalli D, Rastogi P, Gelber Rd, de Azambuja E, Fielding A, Balmaña J, Domchek SM, Gelmon KA, Hollingsworth SJ, Korde LA, Linderholm B, Bandos H, Senkus E, Suga JM, Shao Z, Pippas AW, Nowecki Z, Huzarski T, Ganz PA, Lucas PC, Baker N, Loibl S, McConnell R, Piccart-Gebhart M, Schmutzler R, Steger GG, Costantino JP, Arahmani A, Wolmark N, Mcfadden E, Karantza V, Lakhani SR, Yothers G, Campbell C, Geyer CE Jr
Jaar : 2021
Journal : N Engl J Med
Volume : 384
Pagina's : 2394-2405

Mortality in adult patients with solid or hematological malignancies and SARS-CoV-2 infection with a specific focus on lung and breast malignancies: a systematic review and meta-analysis.

Auteurs : Tagliamento M, Agostinetto E, Bruzzone M, Ceppi M, Saini KS, de Azambuja E, Punie K, Westphalen CB, Morgan G, Pronzato P, Del Mastro L, Poggio F, Lambertini M
Jaar : 2021
Journal : Crit Rev Oncol Hematol
Pagina's : 103365

Heparanase: a potential marker of worse prognosis in estrogen receptor-positive breast cancer.

Auteurs : Zahavi T, Salmon-Divon M, Salgado R, Elkin M, Hermano E, Rubinstein AM, Francis PA, Di Leo A, Viale G, de Azambuja E, Ameye L, Sotiriou C, Salmon A, Kravchenko-Balasha N, Sonnenblick A
Jaar : 2021
Journal : NPJ Breast Cancer
Volume : 7
Pagina's : 67

Antibody-drug conjugates, immune-checkpoint inhibitors, and their combination in breast cancer therapeutics.

Auteurs : Saini KS, Punie K, Twelves C, Bortini S, de Azambuja E, Anderson S, Criscitiello C, Awada A, Loi S
Jaar : 2021
Journal : Expert Opin Biol Ther
Volume : 21
Pagina's : 945-962

Body Mass Index and Weight Change in Patients With HER2-Positive Early Breast Cancer: Exploratory Analysis of the ALTTO BIG 2-06 Trial.

Auteurs : Martel S, Lambertini M, Agbor-Tarh D, Ponde NF, Gombos A, Paterson V, Hilbers F, Korde L, Manukyants A, Dueck A, Maurer C, Piccart-Gebhart M, Moreno-Aspitia A, Desmedt C, Di Cosimo S, de Azambuja E
Jaar : 2021
Journal : J Natl Compr Canc Netw
Volume : 19
Pagina's : 181-189